SMO and mesothelioma: GEPIA database analysis showed that the overall and disease-free survival rates of mesothelioma patients in the SMO and GLI1 high expression groups were significantly lower than those in the low expression group, with statistically significant differences (P < 0.05, Figures 3(a)–3(d)).